XOMA Royalty Corp. ( XOMA) - Stock Earnings
XOMA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 13, 2026 AfterMarket | — / — | — | — / — | — |
XOMA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 14.1 million USD | 9.4 million USD |
| 2025Q4 | 6.1 million USD | 1.4 million USD |
| 2026Q1 | 4.5 million USD | 12.3 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
XOMA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -40.8 million USD | 4.8 million USD |
| 2024 | -13.8 million USD | 28.5 million USD |
| 2025 | 31.7 million USD | 52.1 million USD |
| 2026 Est. | — | — |
XOMA
Price: $41.97
Dividend Yield: 5.18%
Earnings Per Share: 1.57 USD
P/E Ratio: 26.53
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 14100
Ebitda: 28.3 millionMarket Capitalization: 522.8 million